| Stage | HP | % of rev | HNI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.0B | 100.00% | $1.5B | 100.00% | HNI ×1.42 |
| Gross profit | $305M | 29.52% | $647M | 43.96% | HNI +14.4pp |
| Operating income | $188M | 18.19% | $92M | 6.26% | HP +11.9pp |
| Pre-tax income | $151M | 14.54% | $71M | 4.84% | HP +9.7pp |
| Net income | $78M | 7.55% | $51M | 3.47% | HP +4.1pp |
| Stage | HP | HNI | Gap · A − B |
|---|---|---|---|
| Revenue | $1.0B100.00% | $1.5B100.00% | HNI ×1.42 |
| Gross profit | 29.52%$305M | 43.96%$647M | HNI +14.4pp |
| Operating income | 18.19%$188M | 6.26%$92M | HP +11.9pp |
| Pre-tax income | 14.54%$151M | 4.84%$71M | HP +9.7pp |
| Net income |
| 7.55%$78M |
| 3.47%$51M |
| HP +4.1pp |
No shared counterparties.